Bicara Therapeutics Inc. Common Stock

BCAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.01

-$0.63 (-2.78%)

At close: Sep 21, 2026, 4:00 PM ET

$22.01

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.49B

Enterprise Value $950.05M

Beta -0.82

Average Volume 657K

Shares Outstanding (Diluted) 67.93M

Shares Change YoY 24.55%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US0554771032

Price Performance

Price Change 1M -7.2%

Price Change 3M -12.0%

Price Change 6M 17.8%

Price Change YTD 34.4%

Price Change 1Y 104.7%

Price Change 3Y -6.0%

Price Change 5Y -6.0%

1M CAGR (ann.) -17.7%

1Y CAGR (ann.) 106.4%

5Y CAGR (ann.) N/A

All-Time CAGR -1.6%

Valuation

PE Ratio -7.10

Forward PE N/A

PEG Ratio 0.17

Forward PEG -1.68

PS Ratio N/A

Forward PS N/A

PB Ratio 3.08

P/FCF Ratio -10.69

P/Adj. FCF Ratio -9.19

P/OCF Ratio -11.06

EV/Sales N/A

EV/EBIT -5.13

EV/EBITDA -5.15

EV/FCF -7.02

Earnings Yield -14.1%

FCF Yield -9.3%

Adj. FCF Yield -10.9%

Financial Health

Net Cash $496.1M

Total Debt $1.16M

Cash & Short-Term Investments $497.26M

Total Assets $512.24M

Current Ratio 11.59

Quick Ratio 11.59

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -115.95

Interest Coverage 0.00

Altman Z-Score 19.13

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -16.4%

Returns

Return on Assets -36.2%

Return on Equity -41.5%

Return on Invested Capital -43.0%

Return on Capital Employed -43.1%

Return on Tangible Assets -36.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -46.4%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -47.0%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 9.8%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $32.57

Price Target Upside 48.0%

Cash Flow

Operating Cash Flow $-134.85M

Free Cash Flow $-135.25M

Adj. Free Cash Flow $-157.41M

FCF Per Share -$1.99

OCF Per Share -$1.99

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-201.99M

EBITDA $-184.38M

Net Income $-185.36M

EPS (Diluted) -$3.10

Revenue / Employee N/A

Profit / Employee $-1.8M

Employees 103